Blacks Brokers are pleased to announce the successful sale of Oxford Meditech Limited, a well-established medical technology business based in Oxfordshire, England. This sale marks a significant transition for the company, which has built a strong reputation as a trusted distributor and service provider for international and UK-based medical equipment manufacturers.
Originally founded in 1993 as RTS Services, the business rebranded to Oxford Meditech Limited in 2002 following its incorporation. Over the years, it has become a key UK distributor for VANTE (USA), Ljungberg & Kogel (Sweden), and Kajavida (UK), providing global sales and support services. With a legacy spanning nearly three decades, the company has cultivated an impressive portfolio of repeat customers, largely driven by word-of-mouth recommendations and strategic advertising efforts.
The business has historically been well-suited to a hands-on owner-operator and, due to our client’s plans for retirement, was placed on the market, presenting an excellent acquisition opportunity. Its strong financial standing—demonstrated by an annual turnover of £118,335 and a gross profit of £69,506 for the year ending September 2023—combined with an extensive list of long-standing maintenance contracts, made it a compelling investment. Key customers include NHS Blood & Transplant laboratories, leading UK hospitals, and renowned biotech companies, further strengthening its market position.
While based in Oxfordshire, Oxford Meditech Limited operates internationally and offers flexibility in terms of relocation. The new owners inherit not only the business’s strong brand and industry reputation but also its valuable client contracts and key supplier relationships, ensuring a seamless transition and continued success.
Chelsea Melnyk, who facilitated the sale on behalf of [Brokerage Firm Name], commented:
“We are delighted to have successfully brokered the sale of Oxford Meditech Limited. This business has been built on a foundation of reliability and exceptional service, making it highly attractive to buyers in the medical technology sector. The new owners have acquired a well-respected and profitable operation with ample potential for further growth. We wish both our client and the new proprietors every success in the future.”
With limited competition in the sector and a solid reputation, there remains significant scope for business development through the expansion of contracts with existing and new clients. A dedicated marketing strategy targeting hospitals and private healthcare facilities could further enhance growth opportunities.
For further details or media inquiries, please contact us on 0333 370 0000.
To find out more about the market, or for a confidential chat about your business options, please contact [email protected] or 0333 370 0000.
Book Your Call Here Now